HomeComparePKCPY vs SBUX

PKCPY vs SBUX: Dividend Comparison 2026

PKCPY yields 2.72% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKCPY wins by $259.70M in total portfolio value
10 years
PKCPY
PKCPY
● Live price
2.72%
Share price
$1.68
Annual div
$0.05
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$259.86M
Annual income
$242,738,078.54
Full PKCPY calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — PKCPY vs SBUX

📍 PKCPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKCPYSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKCPY + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKCPY pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKCPY
Annual income on $10K today (after 15% tax)
$231.43/yr
After 10yr DRIP, annual income (after tax)
$206,327,366.76/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, PKCPY beats the other by $206,266,900.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKCPY + SBUX for your $10,000?

PKCPY: 50%SBUX: 50%
100% SBUX50/50100% PKCPY
Portfolio after 10yr
$130.02M
Annual income
$121,404,607.50/yr
Blended yield
93.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

PKCPY
No analyst data
Altman Z
2.8
Piotroski
5/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKCPY buys
0
SBUX buys
0
No recent congressional trades found for PKCPY or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKCPYSBUX
Forward yield2.72%2.84%
Annual dividend / share$0.05$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%48.3%
Portfolio after 10y$259.86M$167.0K
Annual income after 10y$242,738,078.54$71,136.45
Total dividends collected$258.57M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: PKCPY vs SBUX ($10,000, DRIP)

YearPKCPY PortfolioPKCPY Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$11,245$544.55$11,121$420.68+$124.00PKCPY
2$13,176$1,144.52$12,548$648.40+$628.00PKCPY
3$16,605$2,506.79$14,440$1,013.98+$2.2KPKCPY
4$23,673$5,905.02$17,068$1,617.30+$6.6KPKCPY
5$41,065$15,735.07$20,912$2,649.52+$20.2KPKCPY
6$94,959$51,019.63$26,875$4,499.29+$68.1KPKCPY
7$322,127$220,520.76$36,771$8,014.12+$285.4KPKCPY
8$1,742,931$1,398,255.13$54,542$15,197.11+$1.69MPKCPY
9$16,006,121$14,141,184.48$89,602$31,242.49+$15.92MPKCPY
10$259,864,628$242,738,078.54$167,011$71,136.45+$259.70MPKCPY

PKCPY vs SBUX: Complete Analysis 2026

PKCPYStock

PT AKR Corporindo Tbk, a logistics and supply chain company, engages in distribution and trading of petroleum and basic chemical products primarily in Indonesia. It operates through four segments: Trading and Distribution, Logistics Services, Manufacturing, and Industrial Estate. The Trading and Distribution segment is involved in the distribution of petroleum products and various basic chemicals, such as caustic soda, sodium sulphate, PVC resins, and soda ash. The Logistics Services segment offers various logistics services, including rental of storage tanks and warehouses, bagging, port handling, and transportation services primarily for liquid and solid chemical, and petroleum products. The Manufacturing segment produces and sells adhesive materials. The Industrial Estate segment leases and sells industrial and port estates. The company was formerly known as PT Aneka Kimia Raya Tbk and changed its name to PT AKR Corporindo Tbk in September 2004. The company was incorporated in 1977 and is headquartered in Jakarta, Indonesia. PT AKR Corporindo Tbk is a subsidiary of PT Arthakencana Rayatama.

Full PKCPY Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this PKCPY vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKCPY vs SCHDPKCPY vs JEPIPKCPY vs OPKCPY vs KOPKCPY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.